Neonatal disorders often require specialized treatments that have not been extensively studied in adult populations. Regulatory approval ensures that these treatments are rigorously tested for safety and efficacy in neonates, thereby minimizing risks and optimizing outcomes. Given the delicate nature of neonatal health, it is crucial to adhere to stringent regulatory standards.
